Fetal Scalp pH During Labour: is it Worth Repeating

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Completed
CT.gov ID
NCT05900596
Collaborator
(none)
130
1
5.9
22

Study Details

Study Description

Brief Summary

In order to reduce the cesarean sections rate, an adjunctive test is recommended in case of non-reassuring fetal heart rate tracing. In France, the reference adjunctive test is fetal scalp blood sampling. However, there is no study about the repetition of fetal blood sampling. Our hypothesis is that the repetition of fetal blood sampling is useful when fetal heart rate stays non-reassuring and may lead to vaginal delivery without impair neonatal prognostic. Therefore, our objective was to compare the patients with three or more fetal blood sampling with the patients with one or two.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Fetal blood sampling

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
130 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Fetal Scalp pH During Labour: is it Worth Repeating
Actual Study Start Date :
Feb 1, 2022
Actual Primary Completion Date :
Jul 31, 2022
Actual Study Completion Date :
Jul 31, 2022

Arms and Interventions

Arm Intervention/Treatment
pH < 3

Patients one or two fetal blood sampling

Diagnostic Test: Fetal blood sampling
Fetal scalp blood sampling and analysis

pH > 3

Patients with three or more fetal blood sampling

Diagnostic Test: Fetal blood sampling
Fetal scalp blood sampling and analysis

Outcome Measures

Primary Outcome Measures

  1. Delivery [baseline]

    Vaginal delivery, operative delivery, cesarean section

Secondary Outcome Measures

  1. Apgar score [baseline]

    value of Apgar score at five minutes of life

  2. umbilical cord pH [baseline]

    value of umbilical cord pH

  3. umbilical cord lactates [baseline]

    value of umbilical cord lactates

  4. neonatal care intensive unit transfer [baseline]

    rate of neonatal care intensive unit transfer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • One fetal blood sampling during labour or more

  • Singleton pregnancy

  • Gestational age equal or above 37 weeks

  • No contra-indication of fetal blood sampling

  • No pregnancy complication

Exclusion Criteria:
  • Sampling failure

  • Incomplete file

Contacts and Locations

Locations

Site City State Country Postal Code
1 Regional University Maternity of Nancy Nancy Meurthe-et-Moselle France 54000

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TOURNIER Mathilde, Resident, Obstetrics and Gynecology, Principal Investigator, Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT05900596
Other Study ID Numbers:
  • 2023PI036
First Posted:
Jun 12, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by TOURNIER Mathilde, Resident, Obstetrics and Gynecology, Principal Investigator, Central Hospital, Nancy, France

Study Results

No Results Posted as of Jun 15, 2023